Dabigatrán Etexilato Combix

Dabigatran Etexilate Combix is an oral medication used for blood thinning and preventing blood clots. It is manufactured by Laboratorios Combix, S.L.U. in the EU.

Dabigatran Etexilate Combix is primarily used for blood thinning to prevent blood clots. It is often prescribed for conditions where there is a risk of clot formation, such as atrial fibrillation or after certain types of surgery. The medication works by inhibiting the formation of blood clots, which can help reduce the risk of stroke and other complications.

Common effects of Dabigatran Etexilate Combix may include bleeding more easily than usual. Some users might experience bruising, nosebleeds, or prolonged bleeding from cuts. It is important to monitor for any signs of unusual bleeding and consult a healthcare provider if concerns arise.

Dabigatran Etexilate Combix should be handled with care, especially if you have a history of bleeding disorders or are undergoing surgery. It is important to follow the prescribed dosage and inform your healthcare provider about any other medications you are taking. Always store the medication as directed and keep it out of reach of children.

Dabigatran Etexilate Combix may interact with other medications, including blood thinners, NSAIDs, and certain antibiotics. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol consumption should also be moderated, as it can increase the risk of bleeding.